Exosome diagnostic and therapeutic products are the medical instruments, which imply in the exosome-based research activities, used primarily in the investigation of various diseases, such as cancer and cardiac diseases, and others. The adoption of exosome instruments is increased among the healthcare and research professionals. The healthcare and research professionals provide immediate direction for the accurate diagnosis of diseases. In addition, technological advancements in the exosome isolation instruments attract end users to adopt the instruments for the isolation of micro and nanovesicle from the various types of body fluids.
Global The global exosome diagnostic and therapeutic market size was valued at $224.34 million in 2020, and is estimated to reach $2.9 billion by 2030, growing at a CAGR of 29.4% from 2021 to 2030.
Download Sample PDF at:
https://www.alliedmarketresearch.com/request-sample/1723
Alarming rise in prevalence of cancer & infectious disease and increase in number of approval for exosome therapeutics & diagnostics are expected to notably contribute toward the growth of the global exosome diagnostic & therapeutic market during the forecast period.
Covid-19 scenario-
- Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.
- This trend is pretty likely to continue till the pandemic is completely over.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:
https://www.alliedmarketresearch.com/purchase-enquiry/1723
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
Ask to Our Industry Expert: https://www.alliedmarketresearch.com/connect-to-analyst/1723
North America garnered the major share in 2020-
Based on region, North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.
Key players in the industry-
- Exosome Diagnostics Inc.
- NanoSomix Inc.
- Thermo Fisher Scientific Inc.
- Malvern Instruments Ltd.
- System Biosciences Inc.
- NX Pharmagen
- Aethlon Medical, Inc.
- Sistemic Inc.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
For Additional Information OR Media Enquiry, Please Mail Us At: